Case report: Renal and combined liver/renal transplant from a donor with renal cell carcinoma (2001)

Ready to upload
Record number: 
Adverse Occurrence type: 
MPHO Type: 
Estimated frequency: 
(Council of Europe, 2018): To provide a valid assessment, complete tumour resection (R0) prior to transplantation is required for the acceptance of all organs; additionally, tumour-free margins are a prerequisite for transplant of the affected kidney. The contralateral kidney should always be examined for synchronous RCC. RCC < 1 cm (Stage T1a AJCC 8th ed.) and nucleolar grade I/II (Fuhrman grade I/II) can be considered minimal risk for transmission. RCC 1-4 cm (Stage T1a AJCC 8th ed.) and nucleolar grade I/II (Fuhrman grade I/II) are considered low risk. RCC > 4-7 cm (Stage T1b AJCC 8th ed.) and nucleolar grade I/II (Fuhrman grade I/II) are considered intermediate risk. RCC > 7 cm (Stage T2 AJCC 8th ed.) and nucleolar grade I/II (Fuhrman grade I/II) are considered high risk. RCC with extension beyond the kidney (Stages T3 or T4 AJCC 8th ed.) is considered a contraindication to transplant. All RCC with nucleolar grade III/IV (Fuhrman grade III/IV) are considered high risk for transmission. Contralateral kidneys and other organs that are uninvolved by carcinoma are considered to represent minimal risk for transplantation when the RCC in the involved kidney is 4 cm or less and Fuhrman or nucleolar grade I-II. Followup surveillance is recommended. In the case of a donor with a history of renal cell carcinoma, the transmission risk of treated RCC depends on the recurrence-free follow-up period. In general, in the first 5 years after initial diagnosis, risk categories correspond to those stated above (RCC diagnosed during donor procurement) if there is no suspicion of tumour recurrence in the donor. After this time, the risk of advanced stages may decrease.
Time to detection: 
N/A. Renal cell carcinoma 1.0 cm detected in donor kidney by biopsy after transplantation of liver and other kidney into two recipients. Kidney with tumor was not used. No tumor was seen in either recipient with 4 year followup.
Alerting signals, symptoms, evidence of occurrence: 
Demonstration of imputability or root cause: 
Groups audience: 
Suggest new keywords: 
Case report
Deceased donor
Kidney transplant
Kidney recipient
Liver transplant
Liver recipient
Histopathological examination
Renal cell carcinoma
Therapy discussed
Reference attachment: 
Suggest references: 
Carver BS, Zibari GB, Venable DD, Eastham JA. Renal cell carcinoma detected in a cadaveric donor after orthotopic liver and contralateral renal transplantation in two recipients: four-year follow-up. Transplantation. 2001 May 15;71(9):1348-9. doi: 10.1097/00007890-200105150-00031. PMID: 11397977.
Uploaded MN 5/8/22 first review CLFF 5/24/22 2nd review MN 5/28
Expert comments for publication: 
This is an early case report demonstrating low risk of transmission with small and early stage renal cell carcinoma.